¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) ´ëÇѵÎÅëÇÐȸ2021 Ãá°èÇмú´ëȸ : 2021-04-11

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) ´ëÇѵÎÅëÇÐȸ2021 Ãá°èÇмú´ëȸ : 2021-04-11
±³À°ÀÏÀÚ : 2021-04-11
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À° (ÃßÈÄ »çÀüµî·ÏÀÚ ÇÑÇØ °³º°ÀûÀ¸·Î Á¢¼Ó »çÀÌÆ® ¸µÅ© ¾È³» ¿¹Á¤)  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) ´ëÇѵÎÅëÇÐȸ2021 Ãá°èÇмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇѵÎÅëÇÐȸ
´ã´çÀÚ : ´ëÇѵÎÅëÇÐȸ ¿î¿µ»ç¹«±¹
¿¬¶ôó : 02-476-6718  
À̸ÞÀÏ : headache@ls-comm.co.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤½Å°Ç°­ÀÇÇаú, ½Å°æ¿Ü°ú, À̺ñÀÎÈÄ°ú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú, Áø´Ü°Ë»çÀÇÇаú, °¡Á¤ÀÇÇаú, ÀÀ±ÞÀÇÇаúÀÇÇб³À°,      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 15ºÐ  
¼¼ºÎ¼ö°­·á : 60,000¿ø      
ºñ°í Æò»ýȸ¿ø¹×¿¬È¸ºñ³³ºÎÁ¤È¸¿ø 30,000¿ø, ¿¬È¸ºñ¹Ì³³Á¤È¸¿ø 30,000¿ø,ºñȸ¿ø 60,000¿ø, Àü°øÀÇ¹× ±âŸȸ¿ø&±ºÀÇ°ü¹× °øº¸ÀÇ µî·Ïºñ¸éÁ¦      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â¶óÀΠ09:10~09:30 Potential AI application in headache clinic  ±èöȣ(ÇѸ²ÀÇ´ë ½Å°æ°ú) 
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â¶óÀΠ09:30~09:50 Potential biomarkers in migraine  ¼ÕÁ¾Èñ(ÇѸ²ÀÇ´ë ½Å°æ°ú) 
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â¶óÀΠ09:50~10:10 COVID-19 and headache  ¾ÈÁø¿µ(¼­¿ïÀÇ·á¿ø ½Å°æ°ú) 
È޽Ġ04¿ù 11ÀÏ ¿Â¶óÀΠ10:10~10:30 È޽Ġ -(-) 
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â¶óÀΠ10:30~11:45 Oral Presentation  -(-) 
½Ä»ç 04¿ù 11ÀÏ ¿Â¶óÀΠ11:45~12:50 ÃÑȸ,¿ì¼ö±¸¿¬»ó ½Ã»ó ¹× LUNCH  -(-) 
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â¶óÀΠ12:50~13:05 Targeting CGRP in migraine treatment:: how to apply it in the clinical practice?  ¹ÚÁ¤¿í(°¡Å縯ÀÇ´ë ½Å°æ°ú) 
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â¶óÀΠ13:05~13:20 Targeting CGRP in migraine treatment:: how to apply it in the clinical practice?  ¹®Èñ¼ö(¼º±Õ°üÀÇ´ë ½Å°æ°ú) 
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â¶óÀΠ13:20~13:35 Vascular risk in migraine: does it affect our clinical practice?  ¹Ú±¤¿­(Áß¾ÓÀÇ´ë ½Å°æ°ú) 
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â¶óÀΠ13:35~13:50 Vascular risk in migraine: does it affect our clinical practice?  À̹ÌÁö(¼º±Õ°üÀÇ´ë ½Å°æ°ú) 
È޽Ġ04¿ù 11ÀÏ ¿Â¶óÀΠ13:50~14:00 È޽Ġ -(-) 
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â¶óÀΠ14:00~14:20 Practical evidence-based acute migraine treatment in adults  ¹ÚÈ«±Õ(ÀÎÁ¦ÀÇ´ë ½Å°æ°ú) 
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â¶óÀΠ14:20~14:40 Practical evidence-based preventive migraine treatment in adults  ±èº´¼ö(ºÐ´çÁ¦»ýº´¿ø ½Å°æ°ú) 
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â¶óÀΠ14:40~15:00 Practical evidence-based migraine treatment in children and adolescents  ±ÇÇýÀº(°¡Å縯 °üµ¿ÀÇ´ë ¼Ò¾Æû¼Ò³â°ú) 
È޽Ġ04¿ù 11ÀÏ ¿Â¶óÀΠ15:00~15:10 È޽Ġ -(-) 
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â¶óÀΠ15:10~15:30 Diagnosis & evaluation of cervicogenic headache  ¹è´ë¿õ(°¡Å縯ÀÇ´ë ½Å°æ°ú) 
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â¶óÀΠ15:30~15:50 Interventional treatment of cervicogenic headache  ¹ÚÈÞÁ¤(°¡Å縯ÀÇ´ë ¸¶ÃëÅëÁõÀÇÇаú) 
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â¶óÀΠ15:50~16:10 Physical therapy of cervicogenic headache  ¼­Á¾±Ù(°æºÏÀÇ´ë ½Å°æ°ú) 
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â¶óÀΠ16:10~17:00 Updated treatment of migraine  Cristina Tassorelli(University of Pavia) 
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â¶óÀΠ17:00~17:10 Q & A  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) ´ëÇѵÎÅëÇÐȸ2021 Ãá°èÇмú´ëȸ : 2021-04-11""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) 2021³âµµ ´ëÇÑÅëÁõÇÐȸ ÃÊÀ½ÆÄ ¿¬¼ö°­Á II : 2021-04-11
´ÙÀ½±Û 2021³â ´ëÇѽÉÆóÇ÷°ü¸¶ÃëÇÐȸ Ãá°è Çмú´ëȸ : 2021-04-11
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20910 ¼­¿ï 2024³â Á¦14ȸ °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ³»ºÐºñ³»°ú ¿¬¼ö°­Á : 2024-07-07 0 13 2024-05-28
20909 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø Á¤Çü¿Ü°ú 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-07-07 0 18 2024-05-28
20908 ¼­¿ï Á¦19Â÷ ´ëÇѸðÀ¯¼öÀ¯ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-07 0 14 2024-05-28
20907 °æ±â Á¦2Â÷ ´ëÇѽŰæ¹æ»ç¼±¼ö¼úÇÐȸ Á¤±âÇмú´ëȸ : 2024-07-06 0 11 2024-05-28
20906 °æ±â Á¦ 5ȸ ¿À»ê½ÃÀÇ»çȸ Çмú´ëȸ : 2024-07-06 0 14 2024-05-28
20905 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦3ȸ ¾Æ»êµÎ°æºÎ Æ÷·³ : 2024-07-06 0 19 2024-05-28
20904 ¼­¿ï 2024³â Á¦2ȸ °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ¼øȯ±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-06 0 14 2024-05-28
20903 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day3) : 2024-07-06 0 14 2024-05-28
20902 ¼­¿ï ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ 2024³â ÇÏ°è NeurocrItical Care Essence (NICE) ¾ÆÄ«µ¥¹Ì : 2024-07-06 0 9 2024-05-28
20901 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06 0 4 2024-05-28
20900 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day2) : 2024-07-05 0 5 2024-05-28
20899 ¼­¿ï ÀÓ»ó¼ú±â±³À°¿¬±¸È¸ Á¦16ȸ ÀÓ»ó¼ú±â ¿¬¼ö°­Á : 2024-07-04 0 11 2024-05-28
20898 °æ±â ¿ëÀμ¼ºê¶õ½ºº´¿ø µðÁöÅÐÀÇ·á½ÉÆ÷Áö¾ö -¹Ì·¡ ÀǷḦ À§ÇÑ ±³·ù¿Í Çù·Â : 2024-07-04 0 9 2024-05-28
20897 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day1) : 2024-07-04 0 9 2024-05-28
20896 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ(Àڱ󻸷Áõ½ÄÁõ) : 2024-07-02 0 9 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷